170809 ⎘
Detection or diagnosis of diseases Musculoskeletal or connective tissue disorders
Sub-classes:EXTRACELLULAR VESICLES AS BIOMARKERS AND THERAPEUTICS FOR NEUROMUSCULAR DISORDERS
#2LEAKY JOINT SYNDROME DIAGNOSTICS AND TREATMENTS
#3BIOMARKERS AND USE THEREOF FOR DIAGNOSIS, PREVENTION, AND TREATMENT OF MUSCLE ATROPHY
#4SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID
#5COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE
#6ASSESSING AND TREATING CAVEOLINOPATHY DISEASES
#7CONSTRUCTS, VIRAL VECTORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING LONG NONCODING RNA ANRIL FOR TREATMENT OF DISEASE
#8DETECTING ANTIBODIES USING ANTIGENS
#9BIOMARKER COMPOSITIONS AND METHODS OF USE THEREOF
#10Systems and Methods for Angiogenic Treatment in Wound Healing
#11ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF
#12METHOD FOR EVALUATING SEVERITY OR PROGNOSIS OF MIXED CONNECTIVE TISSUE DISEASE
#13COMPOSITION FOR PREVENTING OR TREATING SKELETAL MUSCLE DISEASE
#14METHODS FOR INHIBITING MUSCLE ATROPHY
#15PROTEOMIC SAMPLE INVESTIGATION METHOD FOR DIAGNOSING RHABDOMYOLYSIS AND KITS FOR IMPLEMENTING SAME
#16COMPOSITIONS AND METHODS FOR DETECTING AND REGULATING FIBRONECTIN-INTEGRIN INTERACTIONS AND SIGNALING
#17COMPOSITION FOR REGULATING OSTEOCLAST DIFFERENTIATION, AND USE THEREOF
#18Type X Collagen Assays and Methods of Use Thereof
#19INFLAMMATORY BIOMARKERS FOR PREDICTING RESPONSIVENESS TO FGF-18 COMPOUND
#20BONE TURNOVER MARKERS ADJUSTMENT
#21COMPOSITION FOR DIAGNOSING MUSCULOSKELETAL DISEASES, COMPOSITION FOR PREVENTING OR TREATING MUSCULOSKELETAL DISEASES, AND USE THEREOF
#22Means and Method for Detecting Aberrant Erythroblasts
#23METHODS FOR PREDICTING AND TREATING LAMENESS
#24AFFINITY LIGAND FOR THE SOLUBLE PART OF FIBROBLAST GROWTH FACTOR RECEPTOR 3 (sFGFR3)
#25MITIGATION AND REVERSAL OF INTESTINAL FIBROSIS AND INFLAMMATION BY INHIBITION OF TL1A FUNCTION
#26Probe for Specifically Detecting Pathological Collagens, and Preparation Method Therefor and Use Thereof
#27SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID
#28INHIBITORS OF KDM5A FOR USE IN TREATMENT OF IDIOPATHIC INFLAMMATORY MYOPATHIES
#29NOVEL METHODS FOR EARLY IDENTIFICATION OF BONE HEALING ABILITY IN INJURED PATIENTS
#30CD8+T-CELL SUBSETS AS MARKERS FOR PREDICTION OF DELAYED FRACTURE HEALING
#31METHOD FOR DIAGNOSING AND TREATING FIBROMYALGIA
#32METHOD AND MEANS FOR DIAGNOSIS OF SPONDYLOARTHRITIS
#33A SERS METHOD FOR ANALYZING A VISCOUS BIOFLUID
#34ASSAY OF ARYLSULFATASE A ENZYMATIC ACTIVITY IN DRIED BLOOD SPOTS BY MASS SPECTROMETRY AND FLUOROMETRY
#35BIOMARKERS FOR JOINT AILMENTS AND USES THEREOF
#36METHODS FOR INHIBITING MUSCLE ATROPHY
#37Compositions for making and using anti-Myostatin antibodies
#38COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND RELATED DISORDERS
#39SELENIUM BINDING PROTEIN 1 DETECTION FROM BODY FLUIDS FOR DIAGNOSIS OF PERACUTE TISSUE DAMAGE
#40Type X Collagen Assays and Methods of Use Thereof
#41DRUG DISCOVERY AND EARLY DISEASE IDENTIFICATION PLATFORM USING ELECTRONIC HEALTH RECORDS, GENETICS AND STEM CELLS
#42BIOMARKERS FOR MITOCHONDRIAL DISEASES AND RELATED METHODS
#43EXTRACELLULAR VESICLES AS BIOMARKERS AND THERAPEUTICS FOR NEUROMUSCULAR DISORDERS
#44DIAGNOSIS METHOD FOR DISEASES ACCOMPANIED BY REDUCED BONE DENSITY
#45METHOD FOR EVALUATING THE ABILITY OF A COMPOSITION TO PREVENT MUSCLE DAMAGE AND FATIGUE; FOOD SUPPLEMENT AND DRUG
#46COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING A GROWTH RELATED DISEASE AND/OR A CLINICAL CONDITION THEREOF
#47METHOD FOR DETECTING SYNOVIAL JOINT INFECTIONS
#48Inflammatory biomarkers for predicting responsiveness to FGF-18 compound
#49Type X Collagen Assays and Methods of Use Thereof
#50Systems and Methods for Early Detection of Fracture Healing
#51Method of treating and prognosing scoliotic patient subgroups
#52Methods for determining whether a patient suffering from rhabdomyolysis achieves a response with a TLR9 antagonist
#53Methods to predict risk of and to stratify sarcopenia and NAD deficiency
#54Non invasive process for the evaluation of the quality of internal dense connective tissues
#55Type X Collagen Assays and Methods of Use Thereof
#56COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PATHOLOGICAL FIBROBLAST CELLS
#57Biomarkers for joint ailments and uses thereof
#58Systems and methods for angiogenic treatment in wound healing
#59Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function
#60CD8 T cell subsets as a biomarker for predicting non-fusion after spinal fusion surgery
#61METHODS OF MEASURING UBIQUITIN-LIKE MODIFICATIONS
#62METHOD AND KIT FOR DIAGNOSIS OF MUSCLE WEAKNESS-RELATED DISEASES USING BLOOD BIOMARKER
#63CD8+T-cell subsets as markers for prediction of delayed fracture healing
#64Compositions and methods for detecting and treating pathological fibroblast cells
#65Methods for inhibiting muscle atrophy
#66Peptides and uses thereof for diagnosing and treating myasthenia gravis
#67Methods for making and using anti-myostatin antibodies
#68Biomarker Panel to Identify Patients at Risk for Peri-Implant Osteolysis
#69Methods for treating sarcopenia and muscle injury
#70MARKER FOR THE CLASSIFICATION, DIAGNOSIS AND TREATMENT OF SCOLIOSIS
#71Therapeutic intervention for osteoporosis
#72Marker and Method for Determining the Composition or Purity of a Cell Culture and for Determining In Vitro the Identity of a Cartilage Cell or Synovial Cell
#73Method for evaluating the ability of a composition to prevent muscle damage and fatigue; food supplement and drug
#74Marker for Prognosis of a Clinical Outcome of an Autologous Intervertebral Disc Cell Transplantation, for Progress Assessment/Progress Monitoring of an Autologous Intervertebral Disc Cell Transplantation, for Assessing the Quality of Intervertebral Disc Cells, for Assessing the Quality of an Implant and/or Medication for Novel Therapies (ATMP) for the Treatment of an Intervertebral Disc Defect, and for Diagnosis of an Intervertebral and/or Spinal Column Defect
#75COMPOSITIONS, DEVICES, AND METHODS OF FIBROMYALGIA SENSITIVITY TESTING
#76Methods for inhibiting muscle atrophy
#77System for detecting infection in synovial fluid
#78RECOMBINANT PICP PROTEIN, AND METHOD FOR PREPARING ANTIBODY SPECIFICALLY BINDING THERETO
#79Methods for reducing the risk of osteoarthritis of the knee
#80ANTIBODIES, COMPOUNDS AND SCREENS FOR IDENTIFYING AND TREATING CACHEXIA OR PRE-CACHEXIA
#81Methods for treating sarcopenia and frailty
#82Method for diagnosing and treating fibromyalgia
#83Systems and methods for early detection of fracture healing
#84KITS FOR STRATIFYING SCOLIOTIC SUBJECTS
#85METHOD FOR EVALUATING ARTICULAR JOINT THERAPEUTICS
#86Type X Collagen Assays and Methods of Use Thereof
#87METHOD OF TREATING AND PROGNOSING SCOLIOTIC PATIENT SUBGROUPS
#88Method of Increasing GIPCR Signalization in the Cells of a Scoliotic Subject
#89DIRECT DETECTION OF MICROORGANISMS IN PATIENT SAMPLES BY IMMUNOASSAY
#90Methods and apparatus for assessment of risk for joint injury
#91Marker sequences for the diagnosis and stratification of systemic sclerosis patients
#92Methods for early identification of bone healing ability in injured patients
#93METHODS FOR QUANTITATIVE ASSESSMENT OF MUSCLE FIBERS IN MUSCULAR DYSTROPHY
#94Anti-pro/latent-myostatin antibodies and uses thereof
#95Method for evaluating articular joint therapeutics
#96Protein assay method specific to TRACP-5b (tartrate resistant acid phosphatase 5b)
#97POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING
#98Methods, agents and compositions for treatment of inflammatory conditions
#99BIOMARKERS PREDICTIVE OF MUSCLE ATROPHY, METHOD AND USE
#100COMPOSITIONS AND METHODS FOR IDENTIFYING AND TREATING CACHEXIA OR PRE-CACHEXIA
#101Pharmaceutical compositions for treating or preventing bone conditions
#102A Diagnostic Marker For Paget's Disease
#103BIOMARKERS FOR SENSITIVE DETECTION OF STATIN-INDUCED MUSCLE TOXICITY
#104Pharmaceutical compositions containing beta-2 microglobulin and methods of treating autoimmune diseases
#105Trans-differentiation of differentiation cells
#106METHOD AND APPARATUS FOR DIAGNOSING BONE TISSUE CONDITIONS
#107METHODS FOR DIAGNOSING AND TREATING MYHRE SYNDROME
#108A METHOD OF INCREASING GIPCR SIGNALIZATION IN THE CELLS OF A SCOLIOTIC SUBJECT
#109Therapeutic target for musculoskeletal inflammation
#110Compositions and methods for characterizing a myopathy
#111Composition comprising a cell sample from a subject with scoliosis and a reagent for detecting PTPμ or PIPK1y
#112COMPOSITIONS FOR CLASSIFYING A HUMAN PEDIATRIC SUBJECT HAVING ADOLESCENT IDIOPATHIC SCOLIOSIS (AIS)
#113Methods for inhibiting muscle atrophy
#114METHOD OF TREATING AND PROGNOSING SCOLIOTIC PATIENT SUBGROUPS
#115Kits for classifying a subject having or at risk for developing idiopathic scoliosis
#116SENSITIVE DIAGNOSTIC ASSAY FOR INCLUSION BODY MYSITIS
#117Methods and apparatus for assessment of risk for joint injury
#118Electrified compositions for determining the risk of developing adolescent idiopathic scoliosis through the use of GI protein receptor
#119GI PROTEIN PHOSPHORYLATION AS MARKER FOR SCOLIOSIS AND SCOLIOSIS PROGRESSION, METHODS OF INCREASING GIPCR SIGNALING IN SCOLIOTIC SUBJECTS
#120Collagen Type X Alpha-1 Assay
#121CHONDROADHERIN FRAGMENTS AS INDICATORS OF INTERVERTEBRAL DISC DEGENERATION
#122Polynucleotides and polypeptide sequences involved in the process of bone remodeling
#123Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3 signaling pathway
#124Medical image processing apparatus and method for medical image processing
#125METHODS OF DIAGNOSING AND TREATING FIBROSIS
#126CTHRC1 RECEPTOR AND METHODS OF USE THEREOF
#127Treatment of muscular dystrophy
#128Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#129METHODS AND ASSAYS FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
#130Method for diagnosing fibromyalgia
#131Method for diagnosing muscular dystrophy
#132TREATING DISEASES BY MODULATING A SPECIFIC ISOFORM OF MKL1
#133Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)
#134Systems and methods for angiogenic treatment in wound healing
#135METHODS AND COMPOSITIONS RELATED TO THE SMCHD1 GENE
#136Compositions and methods for inducing myoblast differentiation and myotube formation
#137Method for diagnosis of pulmonary involvement in systemic sclerosis
#138Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#139System for detecting infection in synovial fluid
#140Compositions and methods for characterizing a myopathy
#141Vascular Tumor Markers
#142Detecting inclusion body myositis
#143Method for increasing specificity of diagnostic tests for autoimmune diseases
#144PEPTIDES IMMUNOREACTIVE WITH AUTOANTIBODIES FROM PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS
#145Osteogenesis promoter
#146METHODS OF TREATING PERIODONTAL INFLAMMATION AND PERIODONTAL BONE LOSS
#147Granzyme A and granzyme B diagnostics
#148Methods for lowering blood glucose
#149Biomarkers for ankylosing spondylitis
#150Means and methods for assessing increased peroxisomal proliferation
#151Treatment of chronic pelvic pain syndrome
#152Biomarkers for sensitive detection of statin-induced muscle toxicity
#153USE OF ALPHA-2-MACROGLOBULIN FOR DETERMINING OSTEONECROSIS DISEASE STATUS AND FOR SCREENING THERAPEUTIC AGENTS FOR PREVENTING OR TREATING OSTEONECROSIS
#154Diagnostic and therapeutic uses of moesin fragments
#155Methods of making antibodies that bind polypeptides involved in the process of bone remodeling
#156Conditional Mst overexpressing construct and conditional myostatin overexpressing transgenic mouse
#157Biomechanical-based methods of diagnosing scoliosis
#158Hypercholesterolemia and tendinous injuries
#159Compositions and methods for characterizing a myopathy
#160METHODS OF STRATIFYING ADOLESCENT IDIOPATHIC SCOLIOSIS, ISOLATED NUCLEIC ACID MOLECULES FOR USE IN SAME AND KITS USING SAME
#161THERAPEUTIC USE OF THE ß2m PROTEIN
#162METHODS OF EVALUATING CELLS AND CELL CULTURES
#163Variants of C-type natriuretic peptide
#164Biomarkers of musculoskeletal disease
#165METHODS AND COMPOUNDS FOR MUSCLE GROWTH
#166Antibodies that bind polypeptides involved in the process of bone remodeling
#167METHODS OF SCREENING FOR COMPOUNDS FOR USE AS MODULATORS OF LEFT-RIGHT ASYMMETRY IN SCOLIOTIC SUBJECTS AND FOR MONITORING EFFICACY OF AN ORTHOPAEDIC DEVICE
#168Biomarkers for sensitive detection of statin-induced muscle toxicity
#169Methods Of Determining Skeletal Maturity
#170Blood Biomarkers for Bone Fracture and Cartilage Injury
#171MYH14 AS CAUSATIVE GENE RESPONSIBLE FOR COMPLEX PHENOTYPE OF PERIPHERAL NEUROPATHY, MYOPATHY, HEARING LOSS AND HOARSENESS, AND DIAGNOSTIC METHOD AND KIT FOR THE COMPLEX PHENOTYPE USING THE SAME
#172Compositions and Methods for Modulation of Bone Density and Biomineralization
#173METHOD OF DETECTING SKELETAL MUSCLE DAMAGE
#174MEANS AND METHODS FOR COUNTERACTING POLYQ EXPANSION DISORDERS
#175NON-SURGICAL APPROACH TO PREVENT AND CORRECT CRANIOFACIAL MALFORMATIONS DURING DEVELOPMENT
#176METHODS OF EVALUATING CELLS AND CELL CULTURES
#177Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
#178Modulation of autophagy and and serotonin for treatment of multiple myeloma related diseases
#179Treatment of muscle disease characterized by insulin resistance
#180Bone Modulators And Methods Therewith
#181RSPONDIN-3 INHIBITION IN BONE DISORDERS
#182Detection and diagnosis of inflammatory disorders
#183Pluripotent Stem Cells for Drug Induced Myopathy and Malignant Hyperthermia
#184Naphthalene-based inhibitors of anti-apoptotic proteins
#185METHOD OF DIAGNOSING ADOLESCENT IDIOPATHIC SCOLIOSIS
#186Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
#187Compositions and Methods to Treat Bone Related Disorders
#188Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease
#189Treatment for spinal muscular atrophy
#190EDTA Resistant S100A12 Complexes (ERAC)
#191METHOD FOR THE DIAGNOSIS OF SYSTEMIC SCLERODERMA OR OF PULMONARY ARTERIAL HYPERTENSION
#192Antibodies that bind polypeptides involved in the process of bone remodeling
#193Methods for differentiating and monitoring parathyroid and bone status related diseases
#194Pharmaceutical compositions for treating or preventing bone conditions
#195Treatment of chronic pelvic pain syndrome
#196Methods of diagnosing and treating fibrosis
#197METHOD OF CLASSIFYING HUMAN SUBJECTS HAVING ADOLESCENT IDIOPATHIC SCOLIOSIS (AIS) AND METHOD FOR SCREENING FOR A COMPOUND USEFUL IN THE TREATMENT OF AIS AND RELATED SYNDROMES CAUSING SPINAL DEFORMITIES
#198Method for detecting lysosomal storage diseases
#199IDENTIFYING PARATHYROID HORMONE AGONISTS AND ANTAGONISTS
#200METHODS OF SCREENING FOR COMPOUNDS FOR USE AS MODULATORS OF LEFT-RIGHT ASYMMETRY IN SCOLIOTIC SUBJECTS AND FOR MONITORING EFFICACY OF AN ORTHOPAEDIC DEVICE
#201Method for identifying compounds useful for treating and/or preventing disease-associated bone loss
#202NELL-1 enhanced bone mineralization
#203METHODS FOR DETERMINING LEVELS OF 1,25 DIHYDROXY VITAMIN D2 AND D3
#204LUPUS ANTICOAGULENT TESTING
#205METHODS FOR THE CLASSIFICATION AND DIAGNOSIS OF SCOLIOSIS THROUGH THE USE OF GI PROTEIN RECEPTOR
#206METHODS FOR DETECTION AND DIAGNOSIS OF A BONE OR CARTILAGE DISORDER
#207Use application of sugar chain-recognizing receptor
#208Diagnosis of collagen IX destruction
#209Procollagen C-proteinase enhancer (PCPE) biomarker for bone formation
#210MARKER FOR DETECTING IL-17-PRODUCING HELPER T CELL, AND METHOD FOR DETECTING IL-17-PRODUCING HELPER T CELL
#211Means and methods for assessing increased peroxisomal proliferation
#212BMP-1 PROCOLLAGEN C-PROTEINASE FOR DIAGNOSIS AND TREATMENT OF BONE AND SOFT TISSUE DEFECTS AND DISORDERS
#213Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#214Granzyme A and granzyme B diagnostics
#215METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF STATIN-INDUCED MYOPATHY
#216Variants of C-type natriuretic peptide
#217Methods and devices for the detection of biofilm
#218Naphthalene-based inhibitors of anti-apoptotic proteins
#219GENE SENSITIVE TO BONE/JOINT DISEASE AND USE THEREOF
#220METHODS OF IDENTIFYING AND USING SNAIL1 INHIBITORY COMPOUNDS IN CHONDRODYSPLASIA TREATMENT AND PREPARATION OF PHARMACEUTICAL COMPOSITIONS
#221Compositions and Methods for Diagnosing and Assessing Inflammatory Myopathies
#222METHODS OF STRATIFYING ADOLESCENT IDIOPATHIC SCOLIOSIS, ISOLATED NUCLEIC ACID MOLECULES FOR USE IN SAME AND KITS USING SAME
#223Conditional Mst overexpressing construct and conditional myostatin overexpressing transgenic mouse
#224Compositions and methods for improving bone mass through modulation of receptors of PTH and fragments thereof
#225TREATMENT FOR SPINAL MUSCULAR ATROPHY
#226METHODS OF DIAGNOSING MUSCLE DAMAGE
#227Blood biomarkers for bone fracture and cartilage injury
#228DIFFERENTIAL DIAGNOSIS FOR SCLERODERMA
#229Method for diagnosis of systemic sclerosis involving an anti-AT1-receptor antibody
#230METHODS FOR IDENTIFYING AGENTS AND THEIR USE FOR THE PREVENTION OR STABILIZATION OF FIBROSIS
#231METHODS OF SCREENING FOR COMPOUNDS FOR USE AS MODULATORS OF LEFT-RIGHT ASYMMETRY IN SCOLIOTIC SUBJECTS AND FOR MONITORING EFFICACY OF AN ORTHOPAEDIC DEVICE
#232Compositions and Methods to Treat Bone Related Disorders
#233Compositions and Methods for Modulating Osteoblast Cell Differentiation and Bone Generation Through HIF-1a
#234MUTATIONS IN CAPILLARY MORPHOGENESIS GENE-2 (CMG-2) AND USE THEREOF
#235Polynucleotides and polypeptide sequences involved in the process of bone remodeling
#236Method for detecting lysosomal storage diseases
#237Novel Monoclonal Anitbody and Use thereof
#238Compositions and Methods for Modulating mTOR Signaling
#239Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)
#240Methods for identifying modulators of eoxin formation
#241Osteogenic compositions comprising an amino acid sequence capable of being phosphorylated by CAMK2
#242METHODS OF DETERMINING SKELETAL MATURITY
#243Gene and Cognate Protein Profiles and Methods to Determine Connective Tissue Markers in Normal and Pathologic Conditions
#244Hypercholestrolemia and tendinous injuries
#245BMP-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders
#246Screening compounds for activity in modulating chloride ion transport
#247METHODS OF TREATING AND DIAGNOSING LAMINOPATHY
#248Method of classifying human subjects having adolescent idiopathic scoliosis
#249Therapeutic angiogenesis for treatment of the spine
#250Pharmaceutical compositions for treating or preventing bone conditions
#251Chn-1/Chip-Antagonists For The Treatment Of Muscular Diseases
#252Methods of Using the Calcineurin A Variant CnA-beta 1
#253Genetic Markers Associated with Scoliosis and Uses Thereof
#254Vascular Tumor Markers
#255Detection and diagnosis of inflammatory disorders
#256Biomarkers For Anti-Nogo-A Antibody Treatment in Spinal Cord Injury
#257Reducing or avoiding muscle cramps
#258Reducing or avoiding muscle cramps
#259NELL-1 enhanced bone mineralization
#260Methods of evaluating cells and cell cultures
#261Diagnosis of collagen IX destruction
#262Compositions and Methods for Treating Disorders Associated with Abnormal Phosphate Metabolism
#263Reducing or avoiding muscle cramps
#264Methods, kits, and antibodies for detecting parathyroid hormone
#265Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis
#266Methods of diagnosing synovial disease in a mammal by detecting bacterial DNA in synovial tissues from dogs with inflammatory knee arthritis and degenerative anterior cruciate ligament rupture
#267Antibody specific for a chondroitin sulphate epitope
#268Methods and compositions for identifying biomarkers
#269Assessment of skeletal growth using measurements of NT-CNP peptides
#270Uncoupled collagen synthesis and degradation assays
#271Methods, kits, and antibodies for detecting parathyroid hormone
#272Methods of determining skeletal maturity
#273GDF-9/BMP-15 modulators for the treatment of bone disorders
#274Osteogenic compositions comprising an amino acid sequence capable of being phosphorylated by CAMK2
#275Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation
#276Methods and kits using a molecular interaction between a Smurf-1 WW domain and LIM mineralization protein isoforms
#277Methods and compositions for treating disorders of the extracellular matrix
#278Hedgehog Kinases and Their Use in Modulating Hedgehog Signaling
#279Anti-myostatin antibodies
#280Methods and compositions for determining the efficacy of a treatment for ankylosing spondylitis using biomarkers
#281Method of diagnosing myasthenia gravis and kits therefor
#282Methods of detecting lubricin
#283Lupus anticoagulant testing
#284Methods for identifying compounds for regulating muscle mass or function using prostanoid IP receptors
#285Assay for neuromuscular diseases
#286Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
#287Compositions and methods for bone formation and remodeling
#288Use of endosialin binding proteins to isolate endosialin positive cells
#289Calcium challenge test for detecting calcium homeostasis disorders
#290Complex formed by N-linked glycoproteins (SIBLINGS) and Factor H
#291Isolated antibodies immunoreactive with synthetic peptides used to detect rheumatoid arthritis
#292Compositions and methods for treating disorders associated with abnormal phosphate metabolism
#293Method for detecting lysosomal storage diseases
#294Mutations in capillary morphogenesis gene-2 (CMG-2) and use thereof
#295Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation
#296Compositions and methods for bone formation and remodeling
#297Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis
#298Mustang, a gene and nuclear protein
#299Method of diagnosing adolescent idiopathic scoliosis and related syndromes
#300Methods for differentiating and monitoring parathyroid and bone status related diseases